These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28776917)

  • 1. Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
    Geriatr Gerontol Int; 2017 Aug; 17(8):1145-1154. PubMed ID: 28776917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comprehensive risk management chart for the prevention of cerebro- and cardiovascular diseases].
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- and Cardiovascular Diseases
    Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):824-59. PubMed ID: 26536749
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Risk Management for the Prevention of Cerebro- Cardiovascular Diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
    J Atheroscler Thromb; 2017 Jul; 24(7):749-764. PubMed ID: 28652526
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases
    Hypertens Res; 2017 Oct; 40(10):847-855. PubMed ID: 28701740
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan.
    Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro-Cardiovascular Diseases
    Clin Exp Nephrol; 2017 Oct; 21(5):743-754. PubMed ID: 28975437
    [No Abstract]   [Full Text] [Related]  

  • 6. The decline in cardiovascular disease: there is still room for improvement.
    Vanhanen H
    Scand Cardiovasc J; 2004 Aug; 38(4):197-9. PubMed ID: 15553929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiovascular disease in women. Why now?].
    Alfonso F; Bermejo J; Segovia J
    Rev Esp Cardiol; 2006 Mar; 59(3):259-63. PubMed ID: 16712750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Build up broad concept of prevention and prevent the pandemic of cardiovascular and cerebrovascular diseases].
    Xu ZM; Dong QT; Yang YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Jun; 42(6):381-3. PubMed ID: 19035037
    [No Abstract]   [Full Text] [Related]  

  • 9. Striking the right balance.
    MacLean DR
    Health Rep; 1994; 6(1):171-3. PubMed ID: 7919077
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Decline in deaths from heart disease and stroke--United States, 1900-1999.
    JAMA; 1999 Aug; 282(8):724-6. PubMed ID: 10463697
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and epidemiological study of eicosapentaenoic acid (EPA) in Japan.
    Tamura Y; Hirai A; Terano T; Saitoh H; Yoshida S
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():140-3. PubMed ID: 1297726
    [No Abstract]   [Full Text] [Related]  

  • 12. The cardiovascular burden of lupus: a complex challenge.
    Schattner A; Liang MH
    Arch Intern Med; 2003 Jul; 163(13):1507-10. PubMed ID: 12860571
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.
    de Vries FM; Kolthof J; Postma MJ; Denig P; Hak E
    PLoS One; 2014; 9(11):e111247. PubMed ID: 25372483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopause and cardiovascular disease.
    van der Graaf Y; de Kleijn MJ; van der Schouw YT
    J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):113-20. PubMed ID: 9219107
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins for millions more?
    Lancet; 2014 Feb; 383(9918):669. PubMed ID: 24560042
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factor pattern for cardiovascular and cerebrovascular disease as observed in the female population of a Swedish community, Strömstad.
    Björkelund C; Bengtsson C
    Scand J Prim Health Care; 1991 Mar; 9(1):11-5. PubMed ID: 2041923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 18. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population.
    Wang Y; Han S; Qin H; Zheng H; Jiang B; Cao Y; Gao Y; Guan L; Jia Q; Jiang Y; Jiao Y; Li S; Li Y; Li Z; Liu W; Ru X; Sun D; Sun H; Wang P; Wang T; Zong L; Guo L; Xie X; Xu Y; Xu Y; Yang X; Yang Y; Zhou M; Wang W;
    Stroke Vasc Neurol; 2020 Sep; 5(3):270-278. PubMed ID: 32792457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 20. Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention.
    Lombardi M; Mercuro G; Fini M; Rosano GM
    Fundam Clin Pharmacol; 2010 Dec; 24(6):699-705. PubMed ID: 20584207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.